Litcius/Paper detail

Dipeptidyl peptidase-4 inhibitors and the risks of autoimmune diseases in type 2 diabetes mellitus patients in Taiwan: a nationwide population-based cohort study

Yi-Chuan Chen, Tien‐Hsing Chen, Chi-Chin Sun, Jau‐Yuan Chen, Shy-Shin Chang, Ling Yeung, Yi‐Wen Tsai

2020Acta Diabetologica24 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineHazard ratioDiabetes mellitusIncidence (geometry)Type 2 Diabetes MellitusPopulationProportional hazards modelDipeptidyl peptidase-4CohortDipeptidyl peptidaseCohort studySubgroup analysisType 2 diabetesGastroenterologyEndocrinologyConfidence intervalEnzymeBiologyOpticsPhysicsEnvironmental healthBiochemistryDiabetes Treatment and ManagementPeptidase Inhibition and AnalysisDiabetes and associated disorders